These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31838136)

  • 1. NALP3 orchestrates cellular bioenergetics to facilitate non-small cell lung cancer cell growth.
    He ZF; Jin XR; Lin JJ; Zhang X; Liu Y; Xu HL; Xie DY
    Life Sci; 2020 Jan; 241():117165. PubMed ID: 31838136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
    Liu JQ; Feng YH; Zeng S; Zhong MZ
    Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
    Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
    Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
    Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
    Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
    Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA-binding protein RBM47 inhibits non-small cell lung carcinoma metastasis through modulation of AXIN1 mRNA stability and Wnt/β-catentin signaling.
    Shen DJ; Jiang YH; Li JQ; Xu LW; Tao KY
    Surg Oncol; 2020 Sep; 34():31-39. PubMed ID: 32891348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
    Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
    Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
    Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T
    J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
    Yan J; Zhang D; Han Y; Wang Z; Ma C
    J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
    Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
    J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498.
    Wang Y; Li Y; He H; Wang F
    Gene; 2019 Dec; 720():144099. PubMed ID: 31479715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
    Liu X; Li J; Huang Q; Jin M; Huang G
    Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing metabolic reprogramming via the SCD1/HMGCR module.
    Liu L; Chai L; Ran J; Yang Y; Zhang L
    Carcinogenesis; 2020 Dec; 41(12):1724-1734. PubMed ID: 32255478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
    Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
    Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.